NCT00410826 · OUTCOME

Safety as Assessed Through Summaries of Adverse Events and Laboratory Test Results by Treatment Arm

Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer · Source last updated 2013-05-10

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: 30 days after the completion of therapy

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

reporting Status: NOT_POSTED
time Frame: 30 days after the completion of therapy
title: Safety as Assessed Through Summaries of Adverse Events and Laboratory Test Results by Treatment Arm
type: SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice